优化循环RNA疫苗用于高级癌症免疫疗法
Hongwu Yu1,2, Yifan Wen1,2, Wenqian Yu1,2
1Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Theranostics
|January 16, 2025
概括
这项研究开发了一个优化的循环RNA (circRNA) 癌症疫苗平台. 与传统mRNA疫苗相比,新型circRNA疫苗的翻译效率提高,免疫反应更强.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 循环RNA (circRNA) 为mRNA疫苗提供了优势,包括稳定性和持续的蛋白质表达.
- 环RNA的内在免疫刺激性质增强了疫苗的潜力.
- 癌症免疫疗法需要新的平台来提高疗效.
研究的目的:
- 设计和优化一个circRNA癌症疫苗平台.
- 选有效的内部核糖体进入点 (IRES) 进行免疫细胞翻译.
- 提高circRNA的翻译效率,以改善癌症免疫治疗.
主要方法:
- 选了29个IRES元素,确定肠道病毒A (EV-A) IRES是最有效的.
- 利用SHAPE-MaP技术分析circRNA二级结构并优化翻译.
- 研究了间隔序列和microRNA识别位点的调节作用.
主要成果:
- EV-A IRES在免疫细胞中表现出卓越的效率.
- 优化的circRNA结构和间隔序列显著提高了翻译效率.
- 与mRNA疫苗相比,circRNA疫苗引起了更强的T细胞反应和优异的瘤预防/治疗.
结论:
- 优化的circRNA疫苗平台为癌症免疫治疗提供了mRNA疫苗的稳定,高效的替代方案.
- 通过circRNA疫苗观察到增强的免疫反应和治疗结果.
- 这项工作确立了基于circRNA的疫苗作为癌症治疗的有希望的策略.
相关概念视频
Cancer Vaccines
336
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
336
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


